Journal Report

Molecular Therapy Oncolytics

Download PDF
Journal Information
Journal Title
Molecular Therapy Oncolytics
Publisher
CELL PRESS
ISSN
2372-7705
E-ISSN
2372-7705
Database
Clarivate
Domain
Not available
Classification History
Year A+ A B C
2026
2025
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Molecular Therapy Oncology: What’s in a name?
Timothy P. Cripe
2023-12 Vol. 31 Pages 100739
DOI: 10.1016/j.omto.2023.100739
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
Jessica A. Minott, Jacob P. van Vloten, Jake G.E. Yates et al.
2023-12 Vol. 31 Pages 100748
DOI: 10.1016/j.omto.2023.100748
Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
Yun Yang, He Wu, Yan Yang et al.
2023-12 Vol. 31 Pages 100747
DOI: 10.1016/j.omto.2023.100747
New advances in cancer therapy targeting TGF-β signaling pathways
Minyue Shou, Hanyu Zhou, Ling Ma
2023-12 Vol. 31 Pages 100755
DOI: 10.1016/j.omto.2023.100755
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
Jiaojiao Ni, Yihui Huang, Chaoqun Li et al.
2023-12 Vol. 31 Pages 100750
DOI: 10.1016/j.omto.2023.100750
Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer
Ramona Meissner, Viktor Wixler, Franziska Paulina Wulfert et al.
2023-12 Vol. 31 Pages 100741
DOI: 10.1016/j.omto.2023.100741
Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate
Zehua Sun, Xiaojie Chu, Cynthia Adams et al.
2023-12 Vol. 31 Pages 100726
DOI: 10.1016/j.omto.2023.09.002
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers
Thanyavi Chinsuwan, Koichi Hirabayashi, Shuji Mishima et al.
2023-12 Vol. 31 Pages 100728
DOI: 10.1016/j.omto.2023.100728
Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases
Annie Yang, Zhifang Zhang, Shyambabu Chaurasiya et al.
2023-12 Vol. 31 Pages 100734
DOI: 10.1016/j.omto.2023.100734
Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment
Nikhil I. Khushalani, Kevin J. Harrington, Alan Melcher et al.
2023-12 Vol. 31 Pages 100729
DOI: 10.1016/j.omto.2023.100729
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 25, 2026 20:57